Page 62 - RPIA_26-3

Inês Mota, Ângela Gaspar, Mário Morais-Almeida

48. Koschel D, Weber CN, Höffken G. Tolerability to etoricoxib in 55. Lee JY, Simon RA, Stevenson DD. Selection of aspirin dosages
patients with aspirin -exacerbated respiratory disease. J Investig for aspirin desensitization treatment in patients with aspirin-
Allergol Clin Immunol 2013;23:275 -80. -exacerbated respiratory disease. J Allergy Clin Immunol
49. Mihaela TA, Popescu FD, Mariana V, Florica P. The safety profile 2007;119:157 -64.
of etoricoxib in autoreactive urticaria. Therapeutics, Pharmaco- 56. Stevenson DD, Hankammer MA, Mathison DA, Christiansen SC,
logy and Clinical Toxicology 2012;16:116 -20. Simon RA. Aspirin desensitization treatment of aspirin -sensitive
50. Corzo JL, Zambonino MA, Muñoz C, Mayorga C, Requena G, patients with rhinosinusitis -asthma: long term outcomes. J Aller-
Urda A, et al. Tolerance to COX -2 inhibitors in children with gy Clin Immunol 1996;98:751 -8.
hypersensitivity to nonsteroidal anti -inflammatory drugs. Br J 57. Comert S, Celebioglu E, Yucel T, Erdogan T, Karakaya G, Oner-
Dermatol 2014;170:725 -9. ci M, et al. Aspirin 300 mg/day is effective for treating aspirin-
51. Woessner KM, White AA. Evidence -based approach to aspirin -exacerbated respiratory disease. Allergy 2013;68:1443 -51.
desensitization in aspirin -exacerbated respiratory disease. J Al- 58. Ibrahim C, Singh K, Tsai G, Huang D, Mazza J, Rotenberg B, et al.
lergy Clin Immunol 2014;133:286 -7.e1 -9. A retrospective study of the clinical benefit from acetylsalicylic
52. Simon RA, Dazy KM, Waldram JD. Update on aspirin desensiti- acid desensitization in patients with nasal polyposis and asthma.
zation for chronic rhinosinusitis with polyps in aspirin -exacerbated Allergy Asthma Clin Immunol 2014;10:64.
respiratory disease (AERD). Curr Allergy Asthma Rep 2015;15:508. 59. Atkinson TJ, Fudin J, Jahn HL, Kubotera N, Rennick AL, Rhorer
53. Alijotas -Reig J, San Miguel -Moncín M, Cisteró -Bahíma A. Aspirin M. What’s new in NSAID pharmacotherapy: oral agents to in-
desensitization in the treatment of antiphospholipid syndrome jectables. Pain Med 2013;14(Suppl 1):S11 -7.
during pregnancy in ASA -sensitive patients. Am J Reprod Immu- 60. Wallace JL, Caliendo G, Santagada V, Cirino G, Fiorucci S. Gas-
nol 2006;55:45 -50. trointestinal safety and anti -inflammatory effects of a hydrogen
54. Santos N, Gaspar A, Livramento S, Sampaio G, Morais -Almeida sulphide -releasing diclofenac derivative in the rat. Gastroenter-
M. Aspirin desensitization in a woman with inherited thrombo- ology 2007;132:261 -71.
philia and recurrent miscarriage. Eur Ann Allergy Clin Immunol
2012;44:256 -7.

220

REVIST A POR TUGUESA DE IMUNO ALERGOLOGIA